Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature

Human Immunology

Volumn 75, Issue 6, 2014, Pages 578-583

  Kheradmand, T ^a   Anthony, T L ^b   Harland, R C ^c   Testa, G ^b   Hart, J ^a   Renz, J ^a   Te, H S ^a   Marino, S R ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN; LIVER ENZYME; METHYLPREDNISOLONE SODIUM SUCCINATE; PANEL REACTIVE ANTIBODY; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY; AMINOTRANSFERASE; AUTOANTIBODY; BLOOD GROUP ABO SYSTEM; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; HLA ANTIGEN; PEPTIDE FRAGMENT;

ACUTE GRAFT REJECTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY MEDIATED REJECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B LYMPHOCYTE; BILIRUBIN BLOOD LEVEL; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; BLOOD SAMPLING; CASE REPORT; CAUCASIAN; COMPLEMENT FIXATION; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; FEMALE; FLOW CYTOMETRY; GRAFT DYSFUNCTION; HEPATIC ARTERY; HISTOPATHOLOGY; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOPATHOLOGY; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER GRAFT; LIVER NECROSIS; LIVER PERFUSION; LIVER RESECTION; LIVER VEIN; LIVER VEIN OBSTRUCTION; LIVING DONOR; MONONUCLEAR CELL; PLASMAPHERESIS; PORTAL VEIN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPOUSE; T LYMPHOCYTE; TREATMENT DURATION; ALLOTRANSPLANTATION; BLOOD; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LIVER TRANSPLANTATION; MALE; PATHOLOGY;

ABO BLOOD-GROUP SYSTEM; ADULT; AUTOANTIBODIES; B-LYMPHOCYTES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PEPTIDE FRAGMENTS; PLASMAPHERESIS; SPOUSES; T-LYMPHOCYTES; TRANSAMINASES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84900510841     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2014.02.010     Document Type: Article

References (35)

1. Farges O., Kalil A.N., Samuel D., Saliba F., Arulnaden J.L., Debat P., et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995, 59(8):1124-1133. [PubMed PMID: 7732558. Epub 1995/04/27. eng.].
2. Urbani L., Mazzoni A., Bianco I., Grazzini T., De Simone P., Catalano G., et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008, 23(2):55-62. [PubMed PMID: 18186527. Epub 2008/01/12. eng.].
3. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003 Jan, 3(1):51-62. [PubMed PMID: 12511875. Epub 2003/01/04. eng.].
4. Knechtle S.J., Kwun J. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009, 29(1):91-101. [PubMed PMID: 19235662. Epub 2009/02/25. eng.].
5. Watson R., Kozlowski T., Nickeleit V., Woosley J.T., Schmitz J.L., Zacks S.L., et al. Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant 2006 Dec, 6(12):3022-3029.
6. Hori T., Egawa H., Takada Y., Oike F., Ogura Y., Ogawa K., et al. Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver transplantation. Transpl Int 2010 Mar 1, 23(3):338-340.
7. Diehl L., Schurich A., Grochtmann R., Hegenbarth S., Chen L., Knolle P.A. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008, 47(1):296-305. [PubMed PMID: 17975811. Epub 2007/11/03. eng.].
8. Musat A.I., Agni R.M., Wai P.Y., Pirsch J.D., Lorentzen D.F., Powell A., et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011, 11(3):500-510. [PubMed PMID: 21342448. Epub 2011/02/24. eng.].
9. O'Leary J.G., Kaneku H., Susskind B.M., Jennings L.W., Neri M.A., Davis G.L., et al. High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant 2011, 11(9):1868-1876. [PubMed PMID: 21672151. Epub 2011/06/16. eng.].
10. Takemoto S.K., Zeevi A., Feng S., Colvin R.B., Jordan S., Kobashigawa J., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004, 4(7):1033-1041. [PubMed PMID: 15196059. Epub 2004/06/16. eng.].
11. Sakashita H., Haga H., Ashihara E., Wen M.C., Tsuji H., Miyagawa-Hayashino A., et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007 Jun, 20(6):676-684.
12. Lunz J., Ruppert K.M., Cajaiba M.M., Isse K., Bentlejewski C.A., Minervini M., et al. Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?. Am J Transplant 2012 Jan, 12(1):171-182.
13. Tait B.D., Susal C., Gebel H.M., Nickerson P.W., Zachary A.A., Claas F.H., et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013 Jan 15, 95(1):19-47.
14. Ruiz R., Tomiyama K., Campsen J., Goldstein R.M., Levy M.F., McKenna G.J., et al. Implications of a positive crossmatch in liver transplantation: a 20-year review. Liver Transpl 2012, 18(4):55-60. [PubMed PMID: 22139972. Epub 2011/12/06. eng.].
15. O'Leary J.G., Klintmalm G.B. Impact of donor-specific antibodies on results of liver transplantation. Curr Opin Organ Transplant 2013 Jun, 18(3):279-284.
16. Castillo-Rama M., Castro M.J., Bernardo I., Meneu-Diaz J.C., Elola-Olaso A.M., Calleja-Antolin S.M., et al. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Liver Transpl 2008 Apr, 14(4):554-562.
17. Hori T., Uemoto S., Takada Y., Oike F., Ogura Y., Ogawa K., et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?. Surgery 2010 Jun, 147(6):840-844.
18. Kaneku H., O'Leary J.G., Taniguchi M., Susskind B.M., Terasaki P.I., Klintmalm G.B. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation. Liver Transpl 2012 Aug, 18(8):984-992.
19. Chen G., Sequeira F., Tyan D.B. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011 Oct, 72(10):849-858.
20. Chin C., Chen G., Sequeria F., Berry G., Siehr S., Bernstein D., et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011 Feb, 30(2):158-163.
21. Sutherland S.M., Chen G., Sequeira F.A., Lou C.D., Alexander S.R., Tyan D.B. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2012 Feb, 16(1):12-17.
22. Goh A., Scalamogna M., De Feo T., Poli F., Terasaki P.I. Human leukocyte antigen crossmatch testing is important for liver retransplantation. Liver Transpl 2010, 16(3):308-313. [PubMed PMID: 20209590. Epub 2010/03/09. eng.].
23. So S.K., Platt J.L., Ascher N.L., Snover D.C. Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation 1987 Jan, 43(1):79-85. [PubMed PMID: 3541328. Epub 1987/01/01. eng.].
24. Dar W., Agarwal A., Watkins C., Gebel H.M., Bray R.A., Kokko K.E., et al. Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. Am J Transplant 2011 Apr, 11(4):841-847.
25. Dahm F., Georgiev P., Clavien P.A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005 Nov, 5(11):2605-2610.
26. Astarcioglu I., Cursio R., Reynes M., Gugenheim J. Increased risk of antibody-mediated rejection of reduced-size liver allografts. J Surg Res 1999 Dec, 87(2):258-262.
27. Aoki T., Sugawara Y., Takahashi M., Kawaguchi Y., Kaneko J., Yamashiki N., et al. Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft. J Gastroenterol 2012, 11. [PubMed PMID: 22328021. Epub 2012/02/14. Eng.].
28. Rosenberg J.C., Jones B., Oh H. Accelerated rejection following offspring-to-mother and husband-to-wife transplants. Clin Transplant 2004 Dec, 18(6):729-733.
29. Hirai T., Ishida H., Toki D., Miyauchi Y., Kohei N., Iida S., et al. Comparison of the acute rejection incidence rate in spousal donor transplantation before and after anti-CD20 antibody (rituximab) protocol as desensitization therapy. Ther Apher Dial 2011, 15(1):89-97.
30. Hathaway M., Gunson B.K., Keogh A.C., Briggs D., McMaster P., Neuberger J.M. A positive crossmatch in liver transplantation-no effect or inappropriate analysis? A prospective study. Transplantation 1997 Jul 15, 64(1):54-59.
31. Bishara A., Brautbar C., Eid A., Scherman L., Ilan Y., Safadi R. Is presensitization relevant to liver transplantation outcome?. Hum Immunol 2002 Sep, 63(9):742-750.
32. Muro M., Marin L., Miras M., Moya-Quiles R., Minguela A., Sanchez-Bueno F., et al. Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre. Transpl Immunol 2005 Jun, 14(2):91-97.
33. Rostron A., Carter V., Mutunga M., Cavanagh G., O'Suilleabhain C., Burt A., et al. A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil. Transpl Int 2005 Nov, 18(11):1298-1301.
34. Aoki T., Sugawara Y., Takahashi M., Kawaguchi Y., Kaneko J., Yamashiki N., et al. Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft. J Gastroenterol 2012, 47(4):486-488. [PubMed PMID: 22328021. Pubmed Central PMCID: 3336056].
35. Kozlowski T., Rubinas T., Nickeleit V., Woosley J., Schmitz J., Collins D., et al. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl 2011 Apr, 17(4):357-368.